Kaycia Wilde
Directeur Technique/Scientifique/R&D chez Zymeworks BC, Inc.
Profil
Kaycia Wilde's current job is Vice President-Clinical Operations at Zymeworks BC, Inc. She previously worked as Head-Clinical Operations Europe at Kite Pharma UK Ltd.
and as Senior Vice President-Operations at Kartos Therapeutics, Inc. She also held the position of Vice President-Clinical Operations at Zymeworks, Inc. from 2021 to 2023.
Dr. Wilde obtained undergraduate and doctorate degrees from the University of Leeds.
Postes actifs de Kaycia Wilde
| Sociétés | Poste | Début |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | 01/03/2021 |
Anciens postes connus de Kaycia Wilde
| Sociétés | Poste | Fin |
|---|---|---|
| ZYMEWORKS INC. | Directeur Technique/Scientifique/R&D | 01/04/2023 |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Corporate Officer/Principal | 01/03/2020 |
Kite Pharma UK Ltd.
 Kite Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Kite Pharma UK Ltd. is a subsidiary of Gilead Sciences, Inc. that engages in research and develops clinical trials. The company is based in London, UK. | Corporate Officer/Principal | - |
Formation de Kaycia Wilde
| University of Leeds | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZYMEWORKS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Health Technology |
Kite Pharma UK Ltd.
Kite Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Kite Pharma UK Ltd. is a subsidiary of Gilead Sciences, Inc. that engages in research and develops clinical trials. The company is based in London, UK. | Commercial Services |
